Search Results 271-280 of 18035 for progesterone

  1. Minnesota Partnership awards 5 collaborative research grants for 2021 - Mayo Clinic News Network

    Dual targeting of aurora-A and progesterone receptor (PR) driven signaling pathways to enhance the therapeutic efficacy of CDK4/6 inhibitors in endocrine ...

  2. A Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients - Mayo Clinic

    IUD progesterone T;; Female condom;; Natural family planning (rhythm method) or breastfeeding;; Fertility awareness;; Withdrawal;; Cervical shield. Exclusion ...

  3. Hirsutism - Diagnosis & treatment - Mayo Clinic

    To check for hirsutism, your healthcare professional gives you a physical exam. You also answer questions about your medical history and any medicines you ...

  4. Conjugated estrogens synthetic a (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  5. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  6. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

    Intrauterine device (non-progesterone T); Vaginal sponge (containing spermicide). Other acceptable forms: 100% commitment to abstinence. Unacceptable forms of ...

  7. Estrogen receptor mRNA directed therapy for triple negative breast cancer

    progesterone receptor, and HER2/neu receptor. Most TNBCs manifest as high grade invasive ductal carcinomas, of which 70-80% display a basal-like pattern of.

  8. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  9. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    Note: Use of oral (estrogen and progesterone), injected or implanted hormonal methods of contraception or intrauterine system (IUS) or any other form of ...

  10. Publications - Savanna Tierney, Ph.D., L.P. - Mayo Clinic

    ... progesterone receptor expression in female rats. Horm Behav. 2017 Nov; 96:31-41 Epub 2017 Sept 18. View PubMed; Tierney SM, Sheppard DP, Kordovski VM, Faytell ...